🔍

FAIRCHEMOR - Fairchem Organic

📊 NSE: FAIRCHEMOR 🏢 Chemicals 📅 Last Updated: 12/13/2025 22:03

📢 Recent Corporate Announcements

Fairchem Organics Q3 FY26 Revenue Drops 12% to ₹100 Cr; EBITDA Margins Squeeze to 4.2%

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 11 Feb 2026, 01:49 PM

Fairchem Organics reported a weak Q3 FY26 with revenue declining 12% YoY to ₹100 crores and EBITDA falling to ₹4 crores due to lower demand from the paint sector and Chinese dumping. Profitability was severely impacted by a duty inversion where raw materials face 16.5% duty while finished products face only 7.5%. Management expects a gradual recovery starting H2 FY27, supported by new trade agreements with the US and EU and the launch of an animal feed plant. The company is also working on cost-saving measures and domestic catalyst replacement to improve margins.

Q3 Revenue stood at ₹100 crores, a 12% YoY decline, while 9M FY26 revenue fell 18% to ₹343 crores.
EBITDA margins compressed to 4.2% in Q3 and 3.97% for 9M FY26, impacted by elevated raw material costs.
Adjusted PAT for the quarter was ₹60 lakhs (0.6% margin) after an ₹88 lakh exceptional item for labor code implementation.
Management highlighted a duty disadvantage with raw material duties at 16.5% versus 7.5% for imported dimer acid.
Animal feed plant is ready and awaiting GMP certification, with a new value-added product slated for Q3 FY27.

💡 Investors should remain cautious as the company faces significant margin pressure from Chinese imports and high raw material duties. Monitor the recovery in export volumes to the US and the commissioning of the animal feed plant in the coming quarters for signs of a turnaround.

Fairchem Organics Releases Q3 FY26 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Feb 2026, 04:52 PM

Fairchem Organics Limited has officially released the audio recording of its earnings conference call held on February 9, 2026. The call focused on the company's unaudited financial performance for the third quarter and the nine-month period ending December 31, 2025. This disclosure is a mandatory regulatory requirement under SEBI (LODR) Regulations, 2015. Investors can access the full recording via the company's investor relations website to gain insights into management's commentary on operational performance.

Audio recording of the Q3 and 9M FY26 earnings call is now available for public access.
The earnings call was conducted on February 9, 2026, at 3:00 PM IST.
The discussion covered financial results for the period ending December 31, 2025.
The filing complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations.
Direct link to the MP3 recording has been provided on the company's official website.

💡 Investors interested in the company's specialty chemical business should listen to the recording to understand management's guidance on margins and raw material costs. No immediate trading action is required based on this procedural filing.

Fairchem Organics Q3 FY26 PAT Plummets 83% YoY to INR 6 Mn Amid Margin Pressure

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 07 Feb 2026, 12:57 PM

Fairchem Organics reported a weak performance for Q3 FY26, with revenue declining 12% YoY to INR 1,001 Mn and PAT (excluding exceptional items) dropping 83% to INR 6 Mn. EBITDA margins contracted significantly to 4.20% from 6.87% a year ago, driven by elevated raw material costs and aggressive pricing from Chinese competitors. The company faced headwinds in the domestic paint segment due to a new market entrant and a temporary halt in US exports. Management expects a recovery in high-margin exports following recent tariff adjustments in the US and potential FTAs with the UK and EU.

Q3 FY26 Revenue fell 11.9% YoY to INR 1,001 Mn, while 9M FY26 revenue dropped 17.8% to INR 3,427 Mn.
EBITDA for Q3 FY26 declined by 46.2% YoY to INR 42 Mn, with margins shrinking by 267 bps to 4.20%.
PAT (excluding exceptional items) saw a sharp decline of 82.9% YoY, reaching only INR 6 Mn for the quarter.
Raw material costs remained high due to a 16.5% custom duty compared to the original 5.5%, impacting Dimer Acid margins.
Successfully concluded a buyback of INR 340 Mn in January 2026, increasing promoter holding to 63.25%.

💡 Investors should exercise caution as the company faces intense margin pressure from high input costs and Chinese competition. Monitor the ramp-up of exports to the US and Europe as the primary catalyst for a potential recovery in profitability.

Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 06 Feb 2026, 05:20 PM

Fairchem Organics reported a weak performance for the quarter ended December 31, 2025, with revenue from operations declining 11.8% YoY to ₹10,013.40 Lakhs. The company swung to a net loss of ₹9.71 Lakhs from a profit of ₹351.78 Lakhs in the previous year's corresponding quarter. Performance was impacted by an exceptional charge of ₹88.27 Lakhs related to new labor code regulations and overall margin compression. For the nine-month period, net profit plummeted by over 91% YoY to ₹184.87 Lakhs.

Revenue from operations decreased to ₹10,013.40 Lakhs in Q3 FY26 from ₹11,357.08 Lakhs in Q3 FY25.
Reported a net loss of ₹9.71 Lakhs for the quarter compared to a profit of ₹351.78 Lakhs YoY.
Nine-month PAT (9M FY26) stood at ₹184.87 Lakhs, a 91.3% decline from ₹2,138.06 Lakhs in 9M FY25.
Recognized an exceptional expense of ₹88.27 Lakhs due to the implementation of the Code on Wages, 2019.
Completed a buyback of 4,25,000 equity shares at ₹800 per share for a total of ₹34 Crores in January 2026.

💡 The significant drop in profitability and revenue suggests severe margin pressure in the specialty chemicals segment. Investors should remain cautious and monitor the company's ability to pass on costs and improve operational efficiency in upcoming quarters.

Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 06 Feb 2026, 05:16 PM

Fairchem Organics Limited reported a challenging Q3 FY26, with revenue from operations declining to ₹10,013.40 Lakhs from ₹11,357.08 Lakhs YoY. The company swung to a net loss of ₹9.71 Lakhs for the quarter, significantly impacted by an exceptional item of ₹88.27 Lakhs related to new labor code regulations. For the nine-month period ending December 2025, net profit plummeted to ₹184.87 Lakhs compared to ₹2,138.06 Lakhs in the previous year. Despite the weak earnings, the company successfully completed a ₹34 Crore share buyback at ₹800 per share in January 2026.

Revenue from operations decreased by 11.8% YoY to ₹10,013.40 Lakhs in Q3 FY26.
Reported a Net Loss of ₹9.71 Lakhs in Q3 FY26 versus a Net Profit of ₹351.78 Lakhs in Q3 FY25.
Exceptional charge of ₹88.27 Lakhs recognized for employee benefit obligations under new Labour Codes.
Completed buyback of 4,25,000 shares at ₹800 each, totaling ₹34 Crores, with shares extinguished on Jan 27, 2026.
Nine-month revenue stood at ₹34,271.98 Lakhs, down from ₹41,711.77 Lakhs in the prior year period.

💡 The sharp decline in profitability and revenue suggests significant operational headwinds in the specialty chemicals sector. Investors should remain cautious and monitor for margin stabilization, as the recent buyback at ₹800 provides a psychological floor but does not offset the weak earnings performance.

Fairchem Organics to Host Q3/9M-FY26 Earnings Conference Call on February 9, 2026

🟡 NEUTRAL ⭐ 3/10

EARNINGS 📅 03 Feb 2026, 01:03 PM

Fairchem Organics Limited has scheduled an earnings conference call for Monday, February 9, 2026, at 3:00 PM IST. The management will discuss the company's unaudited financial results for the third quarter and nine months ended December 31, 2025. The call will be led by the Managing Director & Chairman, Mr. Nahoosh Jariwala, and the CFO, Mr. Bhavesh Shah. This is a standard post-earnings interaction coordinated by Valorem Advisors to provide clarity on operational performance.

Conference call scheduled for February 9, 2026, at 3:00 PM IST.
Agenda focuses on Unaudited Financial Results for Q3 and 9M FY26.
Management representation includes MD & Chairman Nahoosh Jariwala and CFO Bhavesh Shah.
Universal dial-in numbers provided: +91 22 6280 1341 and +91 22 7115 8242.

💡 Investors should track the call for management's commentary on margin sustainability and demand trends in the oleochemicals segment. Pre-registration via the provided Diamond Pass link is recommended for efficient access.

Fairchem Organics Completes Extinguishment of 4.25 Lakh Equity Shares Post-Buyback

🟢 POSITIVE ⭐ 7/10

ROUTINE 📅 31 Jan 2026, 11:05 AM

Fairchem Organics has successfully completed the extinguishment of 4,25,000 equity shares following its recent buyback program. This action has reduced the company's total paid-up share capital from 1,30,20,902 shares to 1,25,95,902 shares, representing a reduction of approximately 3.26%. The extinguishment was finalized on January 27, 2026, in compliance with SEBI Buy-Back Regulations. Such a reduction in the share base typically leads to an improvement in Earnings Per Share (EPS) and Return on Equity (ROE) for existing shareholders.

Extinguished 4,25,000 equity shares of face value Rs. 10 each on January 27, 2026
Total paid-up share capital reduced from INR 13.02 crore to INR 12.60 crore
Total outstanding equity shares decreased from 1,30,20,902 to 1,25,95,902
The buyback tendering period was conducted between January 8 and January 14, 2026
The extinguishment was confirmed by CDSL and verified by secretarial auditors

💡 The reduction in equity base is a positive development that enhances shareholder value through improved financial ratios. Investors should hold their positions as the lower share count will marginally boost future EPS.

Fairchem Organics Completes Buyback of 76,045 Equity Shares at ₹1,315 Per Share

🟡 NEUTRAL ⭐ 6/10

ROUTINE 📅 23 Jan 2026, 12:25 PM

Fairchem Organics Limited has successfully concluded its share buyback program through the tender offer route. The company repurchased 76,045 equity shares at a price of ₹1,315 per share, involving a total capital outlay of ₹10 crore. This buyback has resulted in a reduction of the total paid-up equity capital, which may lead to a marginal improvement in Earnings Per Share (EPS) for remaining shareholders.

Repurchased 76,045 equity shares at a premium price of ₹1,315 per share.
Total buyback size amounted to ₹10 crore, excluding transaction costs and taxes.
The buyback was conducted via the Tender Offer route as per SEBI regulations.
Post-buyback, the total number of equity shares has been reduced, potentially enhancing return ratios.

💡 As the buyback is now complete and shares have been extinguished, investors should focus on the company's operational performance and the resulting impact on EPS in the next quarterly report.

Fairchem Organics Submits Q3 FY26 SEBI Demat Compliance Certificate

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 07 Jan 2026, 12:42 PM

Fairchem Organics Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2025. The Registrar and Transfer Agent, MUFG Intime India, confirmed that all dematerialization requests were processed and certificates cancelled within the mandated timelines. The company highlighted that its entire share capital has been in dematerialized form since August 2020. This is a standard administrative disclosure with no impact on business operations.

Quarterly compliance certificate filed for the period ending December 31, 2025.
Entire share capital confirmed to be in dematerialized form since August 26, 2020.
MUFG Intime India Private Limited acted as the Registrar and Transfer Agent for the process.
Unclaimed shares from the previous scheme are held in a dedicated Unclaimed Suspense Account.

💡 This is a routine regulatory filing confirming administrative compliance. No specific action is required from investors at this time.

Fairchem Organics Announces Buyback of 4.25 Lakh Shares at ₹800 Per Share via Tender Offer

🟢 POSITIVE ⭐ 8/10

OTHER 📅 06 Jan 2026, 05:24 PM

Fairchem Organics Limited has issued a Letter of Offer for the buyback of up to 4,25,000 equity shares at a price of ₹800 per share, totaling ₹3,400 lakhs. The buyback represents 3.26% of the total equity and 16% of the company's paid-up capital and free reserves as of March 2025. The process will be conducted via the tender offer route, with the acceptance window open from January 8 to January 14, 2026. The record date for determining eligibility was January 5, 2026.

Buyback of 4,25,000 shares at a fixed price of ₹800 per share via tender route
Total buyback size of ₹3,400 lakhs represents 16% of the company's net worth
Small shareholder entitlement ratio is approximately 29 shares for every 488 shares held
General category entitlement ratio is approximately 55 shares for every 606 shares held
Tendering period scheduled from January 8, 2026, to January 14, 2026

💡 Eligible shareholders should evaluate the premium of the ₹800 buyback price over the current market price and consider tendering their shares before the January 14 deadline.

Fairchem Organics Shareholders Approve ₹34 Crore Buyback at ₹800 Per Share

🟢 POSITIVE ⭐ 8/10

REGULATORY 📅 29 Dec 2025, 03:18 PM

Fairchem Organics Limited has received shareholder approval via postal ballot for a buyback of up to 4,25,000 equity shares. The buyback is priced at ₹800 per share, representing a premium of approximately 14.77% over the closing price on the date of the board's initial approval. The total buyback size is capped at ₹3,400 lakhs, which accounts for 16% of the company's total paid-up equity capital and free reserves. The process will be conducted through the tender offer route, providing an opportunity for shareholders to exit at a premium.

Buyback of up to 4,25,000 fully paid-up equity shares at ₹800 per share
Total buyback size capped at ₹3,400 lakhs, representing 16% of aggregate paid-up capital and free reserves
Buyback to be executed through the 'Tender Offer' route on a proportionate basis
15% reservation of the buyback size (63,750 shares) for small shareholders as per SEBI regulations
The buyback price represents a premium of ~14.16% and ~14.77% over BSE and NSE closing prices as of Nov 20, 2025

💡 Investors should watch for the announcement of the Record Date to determine eligibility for participation in the tender offer. Small shareholders may find this particularly attractive due to the 15% reservation and the premium over current market prices.

Fairchem Organics Sets Jan 5, 2026 as Record Date for Rs 34 Cr Buyback at Rs 800/Share

🟢 POSITIVE ⭐ 7/10

ROUTINE 📅 29 Dec 2025, 02:58 PM

Fairchem Organics Limited has officially fixed January 5, 2026, as the record date for its upcoming share buyback. The company intends to repurchase up to 4,25,000 equity shares at a price of Rs 800 per share, which is a significant premium to recent trading prices. The total buyback size is capped at Rs 34 crore and will be executed through the tender offer route. Shareholders must hold the shares in their demat accounts by the record date to be eligible for participation.

Buyback of up to 4,25,000 equity shares at a fixed price of Rs 800 per share
Total aggregate amount for the buyback is INR 3,400 lakhs (Rs 34 crore)
Record date for determining eligibility is fixed as Monday, January 5, 2026
The process will be conducted via a proportionate tender offer as per SEBI regulations
Shareholder approval for the buyback was previously obtained on December 26, 2025

💡 Investors looking to benefit from the buyback premium should ensure they own the shares before the ex-date to be eligible by the January 5 record date. Evaluate the buyback price against the current market price to determine the potential gains from tendering shares.

Fairchem Organics Shareholders Approve Equity Share Buyback with 99.99% Majority

🟢 POSITIVE ⭐ 7/10

OTHER 📅 26 Dec 2025, 06:18 PM

Fairchem Organics Limited has received overwhelming shareholder approval for its proposed equity share buyback via the tender offer route. The postal ballot results showed that 99.99% of the votes cast, totaling 8,552,615 shares, were in favor of the special resolution. The voting process concluded on December 26, 2025, following a month-long e-voting period. This approval allows the company to proceed with the buyback, which is typically viewed as a positive signal regarding management's confidence in the company's valuation.

Special resolution for buyback of equity shares passed with 99.99% majority support.
A total of 8,552,615 votes were cast in favor, while only 1,034 votes (0.01%) were against.
The buyback will be conducted through the tender offer route as per SEBI regulations.
The voting period for the postal ballot ran from November 26 to December 26, 2025.

💡 Investors should monitor upcoming disclosures for the specific buyback price and record date to evaluate the potential premium. This move suggests a healthy cash position and a commitment to returning value to shareholders.

Fairchem Organics to Close Trading Window from Jan 1, 2026 for Q3 FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 22 Dec 2025, 04:47 PM

Fairchem Organics Limited has announced the closure of its trading window for all designated persons starting January 1, 2026. This closure is a mandatory regulatory requirement under SEBI Insider Trading regulations ahead of the financial result declaration for the quarter ending December 31, 2025. The window will remain closed until 48 hours after the unaudited financial results are made public. The specific date for the board meeting to approve these results will be communicated separately in the future.

Trading window closure begins on January 1, 2026
Closure pertains to the unaudited financial results for the quarter ending December 31, 2025
Window will reopen 48 hours after the official declaration of results
Complies with SEBI (Prohibition of Insider Trading) Regulations, 2015

💡 This is a routine regulatory filing and does not impact the company's fundamentals. Investors should look out for the upcoming board meeting date to assess the company's Q3 performance.

View All FAIRCHEMOR Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue from operations fell 13.45% in FY25 to INR 5,379 Mn from INR 6,215 Mn in FY24. In H1-FY26, revenue declined 20.1% YoY to INR 2,426 Mn due to weaker offtake from the paints industry and increased competition.

Geographic Revenue Split

Domestic sales accounted for 91.22% of revenue, while export sales contributed 8.78% during Q2-FY26. Exports are currently seeing slower-than-expected scale-up due to regulatory registration requirements in Europe.

Profitability Margins

Net Profit Margin fell from 6.52% in FY24 to 4.09% in FY25, and further collapsed to 0.78% in H1-FY26. This 512 bps YoY decline in H1-FY26 margins is attributed to substantial falls in overall sales and negative operating leverage.

EBITDA Margin

EBITDA margin was 3.87% in H1-FY26, a sharp decline of 618 bps from 10.05% in H1-FY25. Q2-FY26 EBITDA margin stood at 3.77%, down 251 bps YoY, reflecting lower volumes and higher fixed costs relative to sales.

Capital Expenditure

Capital work-in-progress increased from INR 60 Mn in FY24 to INR 137 Mn by H1-FY26. The company reported investing cash outflows of INR 255 Mn in FY25 and INR 106 Mn in H1-FY26 for capacity maintenance and expansion.

Credit Rating & Borrowing

The company's long-term bank facilities were downgraded in June 2025 to CARE A; Stable from CARE A+; Stable. Short-term ratings were downgraded to CARE A1 from CARE A1+. Finance costs fell 11.1% YoY in H1-FY26 to INR 16 Mn.

⚙️ Operational Drivers

Capacity Expansion

The company processed 11,492 MT and sold 10,469 MT during Q2-FY26. Volume terms declined 19.9% on a Q-o-Q basis, reflecting weaker demand from key customer segments like paints.

Raw Material Costs

Total expenses in H1-FY26 were INR 2,332 Mn, representing 96.1% of revenue. The fall in operating profit margin by 26% in FY25 was primarily due to the inability to pass on costs amidst falling sales and increased competition.

Manufacturing Efficiency

Manufacturing efficiency has been impacted by lower volumes, with Q2-FY26 sales volume falling 19.9% QoQ, leading to higher per-unit depreciation costs which rose 7.7% YoY to INR 28 Mn.

📈 Strategic Growth

Growth Strategy

Growth is focused on the strategic ramp-up of Isostearic Acid exports. While currently delayed by European regulatory compliance, the company expects a staggered ramp-up post-completion. Additionally, the Board approved a buyback of INR 34 Cr in Nov 2025 to optimize capital structure.

Products & Services

Specialty chemicals including Isostearic Acid and other organic chemicals primarily sold to the paints and coatings industry.

Brand Portfolio

Fairchem Organics.

New Products/Services

Isostearic Acid is identified as the key strategic growth product, intended to drive export revenue once European regulatory hurdles are cleared.

Market Expansion

Targeting the European market for Isostearic Acid exports; currently in the process of completing necessary regulatory registrations to enable a staggered ramp-up.

Market Share & Ranking

The company maintains a leadership position in the domestic market for its niche specialty chemical products.

Strategic Alliances

Fairfax India, through FIH Mauritius Investment Limited, holds a controlling 52.83% equity stake as of March 31, 2024.

🌍 External Factors

Industry Trends

The specialty chemicals industry is facing a period of subdued demand and heightened competition, leading to a 37% decline in net profit ratios for the company in FY25.

Competitive Landscape

The landscape is becoming more aggressive, with 'increased competition' specifically cited as a negative factor impacting the company's scale and profitability indicators.

Competitive Moat

The moat is built on a leadership position in niche products and long-standing relations with reputed customers. However, this moat is being challenged by increased competition, as evidenced by the 50% drop in Return on Net Worth to 7.39% in FY25.

Macro Economic Sensitivity

Highly sensitive to demand cycles in the domestic paint and coatings industry, which accounts for the majority of the 91.22% domestic revenue share.

Consumer Behavior

Shift toward lower inventory holding or reduced offtake by industrial consumers in the paint sector has led to a 27% decline in the company's debtors turnover ratio.

Geopolitical Risks

Trade barriers in the form of new regulatory registration requirements in Europe are currently hindering the strategic expansion of the export business.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to GPCB (Gujarat Pollution Control Board) norms for effluent and air emissions. Export operations are currently restricted by European regulatory registration requirements.

Environmental Compliance

The company spent INR 1.38 Cr on CSR activities, representing 2% of average net profits. It utilizes GPCB-approved recyclers for hazardous waste disposal.

Taxation Policy Impact

The effective tax rate for H1-FY26 was approximately 32%, with INR 9 Mn tax paid on a PBT of INR 28 Mn.

Legal Contingencies

No fraud was reported by statutory auditors under section 143(12) of the Act. Internal control systems are reported as adequate and audited by a firm of Chartered Accountants.

⚠️ Risk Analysis

Key Uncertainties

The primary uncertainty is the timeline for European regulatory compliance for Isostearic Acid, which is critical for reversing the current revenue de-growth trend.